2025-04-02 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Report

**0. Executive Summary:**

Intuitive Surgical Inc. (ISRG) is a leading developer and provider of robotic-assisted surgery systems.  The company shows a significantly higher cumulative return than the S&P 500 (VOO) over the analyzed period, although recent performance has moderated.  While showing strong profitability, recent price movements suggest caution.


**1. Performance Comparison & Alpha/Beta Analysis:**

Intuitive Surgical Inc. (ISRG) is a company that develops and manufactures robotic surgical systems.  The cumulative return of ISRG (214.76%) significantly outperforms the S&P 500 (VOO) with a cumulative return of 89.83%. The difference is currently 124.9%, placing it in the 77.5th percentile of historical relative performance compared to the S&P 500.

The provided Alpha/Beta analysis reveals varying performance characteristics across different time periods.  While CAGR (Compound Annual Growth Rate) is consistently high, exhibiting robust growth, Alpha fluctuates, showing periods of outperformance and underperformance against the market (Beta). The high Beta values indicate significant market sensitivity.  Capitalization (Cap) shows consistent growth, reflecting the company's expansion.


| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 66.0% | 10.1% | -0.1 | 43.5 |
| 2016-2018  | 77.0% | 49.6% | -0.1 | 57.1 |
| 2017-2019  | 82.0% | 49.6% | 0.2 | 70.5 |
| 2018-2020  | 53.0% | 49.6% | 0.3 | 97.6 |
| 2019-2021  | 100.0% | 18.4% | 0.3 | 128.6 |
| 2020-2022  | 17.0% | 53.7% | 0.3 | 95.0 |
| 2021-2023  | 19.0% | 55.0% | 0.9 | 120.7 |
| 2022-2024  | 103.0% | 55.0% | 0.9 | 186.8 |
| 2023-2025  | 125.0% | 55.0% | 0.8 | 177.2 |


**2. Recent Price Movement:**

* **Closing Price:** $495.27
* **Last Market Price:** $494.85 (a decrease of $0.08 from the previous close)
* **5-Day Moving Average:** $504.77
* **20-Day Moving Average:** $504.96
* **60-Day Moving Average:** $553.02

The current price is below all three moving averages, suggesting a potential downward trend.


**3. Technical Indicators & Expected Return:**

* **Market Risk Indicator (MRI):** 0.4403 (Medium Risk)
* **RSI:** 50.71 (Near neutral; neither overbought nor oversold)
* **PPO:** 0.4483 (Positive, indicating potential bullish momentum)
* **20-Day Relative Strength Change:** -3.7% (Short-term bearish trend)
* **Expected Return (2+ years):** 26.9% (vs. S&P 500)  This suggests a strong potential for outperformance relative to the S&P 500 over the long term. The small price drop is not significant enough to indicate a sharp reversal.

**4. Recent Earnings Analysis:**

The earnings data shows relatively consistent revenue growth, though EPS has fluctuated slightly.  More detailed analysis would require additional information such as year-over-year comparisons and industry benchmarks.

| Date       | EPS  | Revenue     |
|------------|------|-------------|
| 2024-10-18 | 1.59 | $2.04B      |
| 2024-07-19 | 1.48 | $2.01B      |
| 2024-04-19 | 1.54 | $1.89B      |
| 2023-10-20 | 1.18 | $1.74B      |
| 2024-10-18 | 1.18 | $1.74B      | *(Note: Duplicate entry â€“ likely a data error)*


**5. Financial Information:**

Revenue and Profitability show consistent and high profit margins.  Equity and ROE are also growing, indicating a healthy financial position.

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $2.41B | 68.04% |
| 2024-09-30 | $2.04B | 67.41% |
| 2024-06-30 | $2.01B | 68.30% |
| 2024-03-31 | $1.89B | 65.87% |
| 2023-12-31 | $1.93B | 66.24% |

**Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2024-12-31 | $16.43B | 4.17% |
| 2024-09-30 | $15.58B | 3.63% |
| 2024-06-30 | $14.71B | 3.58% |
| 2024-03-31 | $13.96B | 3.90% |
| 2023-12-31 | $13.31B | 4.56% |


**6. Overall Analysis:**

ISRG demonstrates a strong historical performance significantly outpacing the S&P 500.  However, recent price action indicates a potential short-term correction.  High profitability and consistent revenue growth are positive indicators.  The high Beta suggests substantial market sensitivity.  While long-term prospects remain promising based on the high expected return, potential investors should monitor the current price trend and consider the inherent market risk before making investment decisions.  A more in-depth analysis, including a deeper dive into competitive landscape, regulatory factors, and future growth projections, would provide a more comprehensive assessment.  The presence of some data inconsistencies (duplicate entry in earnings data) warrants further investigation of data reliability.
